Cargando…
Management of metabolic syndrome through probiotic and prebiotic interventions
Metabolic syndrome is a complex disorder caused by a cluster of interrelated factors that increases the risk of cardiovascular diseases and type 2 diabetes. Obesity is the main precursor for metabolic syndrome that can be targeted in developing various therapies. With this view, several physical, ps...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263193/ https://www.ncbi.nlm.nih.gov/pubmed/22276249 http://dx.doi.org/10.4103/2230-8210.91178 |
_version_ | 1782221828381474816 |
---|---|
author | Mallappa, Rashmi H. Rokana, Namita Duary, Raj Kumar Panwar, Harsh Batish, Virender Kumar Grover, Sunita |
author_facet | Mallappa, Rashmi H. Rokana, Namita Duary, Raj Kumar Panwar, Harsh Batish, Virender Kumar Grover, Sunita |
author_sort | Mallappa, Rashmi H. |
collection | PubMed |
description | Metabolic syndrome is a complex disorder caused by a cluster of interrelated factors that increases the risk of cardiovascular diseases and type 2 diabetes. Obesity is the main precursor for metabolic syndrome that can be targeted in developing various therapies. With this view, several physical, psychological, pharmaceutical and dietary therapies have been proposed for the management of obesity. However, dietary strategies found more appropriate without any adverse health effects. Application of probiotics and prebiotics as biotherapeutics is the new emerging area in developing dietary strategies and many people are interested in learning the facts behind these health claims. Recent studies established the role of probiotics and prebiotics in weight management with possible mechanisms of improved microbial balance, decreased food intake, decreased abdominal adiposity and increased mucosal integrity with decreased inflammatory tone. Hence, the above “Pharmaco-nutritional” approach has been selected and extensively reviewed to gain thorough knowledge on putative mechanisms of probiotic and prebiotic action in order to develop dietary strategies for the management of metabolic syndrome. |
format | Online Article Text |
id | pubmed-3263193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32631932012-01-24 Management of metabolic syndrome through probiotic and prebiotic interventions Mallappa, Rashmi H. Rokana, Namita Duary, Raj Kumar Panwar, Harsh Batish, Virender Kumar Grover, Sunita Indian J Endocrinol Metab Review Article Metabolic syndrome is a complex disorder caused by a cluster of interrelated factors that increases the risk of cardiovascular diseases and type 2 diabetes. Obesity is the main precursor for metabolic syndrome that can be targeted in developing various therapies. With this view, several physical, psychological, pharmaceutical and dietary therapies have been proposed for the management of obesity. However, dietary strategies found more appropriate without any adverse health effects. Application of probiotics and prebiotics as biotherapeutics is the new emerging area in developing dietary strategies and many people are interested in learning the facts behind these health claims. Recent studies established the role of probiotics and prebiotics in weight management with possible mechanisms of improved microbial balance, decreased food intake, decreased abdominal adiposity and increased mucosal integrity with decreased inflammatory tone. Hence, the above “Pharmaco-nutritional” approach has been selected and extensively reviewed to gain thorough knowledge on putative mechanisms of probiotic and prebiotic action in order to develop dietary strategies for the management of metabolic syndrome. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3263193/ /pubmed/22276249 http://dx.doi.org/10.4103/2230-8210.91178 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Mallappa, Rashmi H. Rokana, Namita Duary, Raj Kumar Panwar, Harsh Batish, Virender Kumar Grover, Sunita Management of metabolic syndrome through probiotic and prebiotic interventions |
title | Management of metabolic syndrome through probiotic and prebiotic interventions |
title_full | Management of metabolic syndrome through probiotic and prebiotic interventions |
title_fullStr | Management of metabolic syndrome through probiotic and prebiotic interventions |
title_full_unstemmed | Management of metabolic syndrome through probiotic and prebiotic interventions |
title_short | Management of metabolic syndrome through probiotic and prebiotic interventions |
title_sort | management of metabolic syndrome through probiotic and prebiotic interventions |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263193/ https://www.ncbi.nlm.nih.gov/pubmed/22276249 http://dx.doi.org/10.4103/2230-8210.91178 |
work_keys_str_mv | AT mallapparashmih managementofmetabolicsyndromethroughprobioticandprebioticinterventions AT rokananamita managementofmetabolicsyndromethroughprobioticandprebioticinterventions AT duaryrajkumar managementofmetabolicsyndromethroughprobioticandprebioticinterventions AT panwarharsh managementofmetabolicsyndromethroughprobioticandprebioticinterventions AT batishvirenderkumar managementofmetabolicsyndromethroughprobioticandprebioticinterventions AT groversunita managementofmetabolicsyndromethroughprobioticandprebioticinterventions |